Gender Male
David McCormick is co-Founder of Anapneo Therapeutics and serves as its Chief Executive Officer. Dr. McCormick has more than 30 years of experience in drug discovery and preclinical development, and has served as Principal Investigator on more than 50 programs supported by the National Cancer Institute and other branches of the National Institutes
of Health. His group designed the family of compounds being developed by Anapneo Therapeutics, and he is directing preclinical toxicology, pharmacology, and other IND-enabling studies of Anapneo lead compounds. His management experience includes nearly 20 years as President/Director of IIT Research Institute (IITRI) in Chicago, where he leads a team of 110 scientists, technicians and support staff. He is also IITRI Professor of Biology at the Illinois Institute of Technology.
